Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 0 | 20,968 | 41,867 | 23,028 |
| Cost of Goods | N/A | N/A | 6,174 | 7,266 | N/A |
| Gross Profit | N/A | N/A | 14,794 | 34,601 | 23,028 |
| Operating Expenses | 26,748 | 28,107 | 136,463 | 122,402 | 112,111 |
| Operating Income | -26,748 | -28,107 | -121,495 | -87,535 | -89,083 |
| Other Income | 8,534 | -1,290 | 2,982 | 2,061 | 642 |
| Pre-tax Income | -18,214 | -29,397 | -118,513 | -85,474 | -88,441 |
| Net Income Continuous | -18,214 | -29,397 | -118,513 | -85,474 | -88,441 |
| Net Income | $-18,214 | $-29,397 | $-118,513 | $-85,474 | $-88,441 |
| EPS Basic Total Ops | -2.46 | -11.42 | -78.79 | -57.37 | -62.67 |
| EPS Basic Continuous Ops | -2.46 | -11.42 | -78.81 | -57.36 | -62.81 |
| EPS Diluted Total Ops | -3.26 | -11.42 | -78.79 | -57.37 | -62.67 |
| EPS Diluted Continuous Ops | -2.34 | -11.42 | -78.81 | -57.36 | -62.81 |
| EPS Diluted Before Non-Recurring Items | -3.26 | -38.16 | -78.88 | -57.27 | -62.67 |
| EBITDA(a) | $-26,853 | $-28,012 | $-119,561 | $-85,601 | $-86,668 |